Publications by authors named "Muaz Ali"
Article Synopsis
- Drugs targeting the calcitonin gene-related peptide (CGRP) pathway represent a new approach for treating migraine, with Zavegepant being the first intranasal CGRP antagonist developed.
- A systematic review of six studies evaluated Zavegepant's safety, efficacy, pharmacokinetics, and tolerability, focusing primarily on two randomized control trials with consistent results.
- Findings suggest that Zavegepant is an effective and well-tolerated treatment option for episodic migraines, demonstrating positive outcomes across various parameters, including adverse events and pain relief.
Unlabelled: Convalescent plasma therapy has gained worldwide notoriety since its inception as a form of soul treatment for terminally ill patients. This study investigates the link between knowledge, attitude, and practice of plasma donation while simultaneously probing the moderative role of age and gender in this context.
Method: A cross-sectional study was undertaken in Rawalpindi, Pakistan, on COVID-19-recovered patients (coronavirus disease 2019).